Michael P. Whyte

Internal Medicine
4921 Parkview Pl Ste 5C
Saint Louis, MO 63110

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications

Integrating AI Scribe Technology into Public Health Workflows: Simulation and Field Evaluation in Disease Case Management.

Integrating AI Scribe Technology into Public Health Workflows: Simulation and Field Evaluation in Disease Case Management.

Journal: Studies in health technology and informatics
Published: May 23, 2026

Hypophosphatasia: Who Among Us Is A Carrier?

Hypophosphatasia: Who Among Us Is A Carrier?

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: December 15, 2025

Hypophosphatasia: who among us is a carrier?

Hypophosphatasia: who among us is a carrier?

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: December 15, 2025

Seventeen-year follow-up of hypophosphatasia diagnosed in middle-aged siblings harboring a novel intronic and a rare missense ALPL gene mutation.

Seventeen-year follow-up of hypophosphatasia diagnosed in middle-aged siblings harboring a novel intronic and a rare missense ALPL gene mutation.

Journal: Bone
Published: September 30, 2025

Corrigendum to "Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)" [Bone 197 (2025) 117477].

Corrigendum to "Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)" [Bone 197 (2025) 117477].

Journal: Bone
Published: August 07, 2025

Duplications within exon 1 of TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK) are associated with tendon avulsion.

Duplications within exon 1 of TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK) are associated with tendon avulsion.

Journal: Bone
Published: January 30, 2025

Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631).

Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631).

Journal: Bone
Published: January 14, 2025

Markedly discordant hypophosphatasia in a young girl.

Markedly discordant hypophosphatasia in a young girl.

Journal: Bone
Published: December 18, 2024

Transmembrane protein 53 craniotubular dysplasia (OMIM # 619727): The skeletal disease and consequent blindness of this new disorder.

Transmembrane protein 53 craniotubular dysplasia (OMIM # 619727): The skeletal disease and consequent blindness of this new disorder.

Journal: Bone
Published: May 21, 2024

Skeletal fluorosis: an uncommon cause, yet a rescue treatment?

Skeletal fluorosis: an uncommon cause, yet a rescue treatment?

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: March 03, 2024

Pediatric hypophosphatasia: avoid diagnosis missteps!

Pediatric hypophosphatasia: avoid diagnosis missteps!

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: December 29, 2023

Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B6 metabolism.

Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B6 metabolism.

Journal: Bone
Published: August 30, 2023
Showing 1-12 of 131

Last Updated: 09/26/2026